Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -21.32x is 77% above its 3-year average of -91.70x, near the high end of its 3-year range (-256.80x–-4.57x).
92.24% below its 12-month average of -11.09x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -4.57x.
INTEREST COVERAGE RATIO
-21.32x
INTEREST COVERAGE RATIO AVG TTM
-11.09x
INTEREST COVERAGE RATIO AVG 3Y
-58.68x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-92.24%
CURRENT VS 3Y AVG
+63.67%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-268.22%
vs the sector median at left
20/20 Biolabs Inc.
Market Cap
$4.23M
Interest Coverage Ratio
-21.32x
TTM Avg
-11.09x
3Y Avg
-58.68x
5Y Avg
N/A
Market Cap
$4.07M
Interest Coverage Ratio
N/A
TTM Avg
11.42x
3Y Avg
11.42x
5Y Avg
7.97x
Market Cap
$4.34M
Interest Coverage Ratio
-765.53x
TTM Avg
1.76x
3Y Avg
1.76x
5Y Avg
1.76x
Market Cap
$4.01M
Interest Coverage Ratio
-994.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.98M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.52M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.60M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.82M
Interest Coverage Ratio
-16.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 20/20 Biolabs Inc. (AIDX) | $4.23M | -21.32x | -11.09x | -58.68x | N/A |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A | N/A | N/A | N/A |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.07M | N/A | 11.42x | 11.42x | 7.97x |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.34M | -765.53x | 1.76x | 1.76x | 1.76x |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $4.01M | -994.05x | N/A | N/A | N/A |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.98M | N/A | N/A | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.52M | N/A | N/A | N/A | N/A |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.60M | N/A | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.82M | -16.26x | N/A | N/A | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.84M | -345.15x | 1.19x | 1.19x | 1.19x |
Interest Coverage
-21.3x
Debt/Equity
0.18
Current Ratio
1.99
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -4.57x |
| 2026-03-31 | -5.41x |
| 2025-12-31 | -7.30x |
| 2025-09-30 | -27.08x |
| 2023-06-30 | -249.04x |
| 2023-03-31 | -256.80x |
